CCM
NXTM

Camber Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Camber Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-820,535
Closed -$10.5M – 48
2014
Q1 		$10.5M Hold
820,535
– – 0.82% 28
2013
Q4 		$8.21M Buy
+820,535
New +$9.31M 0.72% 28

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

Camber Capital Management's NXTM Position: Q2 2014 in Review

Camber Capital Management sold out of NxStage Medical Inc. (NXTM) in Q2 2014, closing a stake of 820,535 shares — an estimated $10.5M sold.

Camber Capital Management first reported a position in NXTM in Q4 2013 and held it in 2 quarters. The position peaked at $10.5M in Q1 2014. 115 funds tracked by Wall St. Rank hold NXTM as of Q2 2014.

  • Camber Capital Management reported no remaining NxStage Medical Inc. position as of Q2 2014 after selling out during the quarter.
  • Camber Capital Management sold 820,535 NxStage Medical Inc. shares in Q2 2014, an estimated $10.5M.
  • Camber Capital Management first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 2 quarters.
  • Camber Capital Management's NxStage Medical Inc. position peaked at $10.5M in Q1 2014.
  • 115 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2014.

Based on Camber Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.